|
1
|
Wakisaka N and Pagano JS: Epstein-Barr
virus induces invasion and metastasis factors. Anticancer Res.
23:2133–2138. 2003.PubMed/NCBI
|
|
2
|
Horikawa T, Yoshizaki T, Kondo S, et al:
Epstein-Barr Virus latent membrane protein 1 induces Snail and
epithelial-mesenchymal transition in metastatic nasopharyngeal
carcinoma. Br J Cancer. 104:1160–1167. 2011. View Article : Google Scholar
|
|
3
|
Liu HP, Chen CC, Wu CC, et al:
Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate
Cdc42 and thereby promote migration of nasopharyngeal carcinoma
cells. PLoS Pathog. 8:e10026902012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chou YC, Chen CL, Yeh TH, et al:
Involvement of recepteur d’origine nantais receptor tyrosine kinase
in Epstein-Barr virus-associated nasopharyngeal carcinoma and its
metastasis. Am J Pathol. 181:1773–1781. 2012.
|
|
5
|
Horikawa T, Yang J, Kondo S, et al: Twist
and epithelial-mesenchymal transition are induced by the EBV
oncoprotein latent membrane protein 1 and are associated with
metastatic nasopharyngeal carcinoma. Cancer Res. 67:1970–1978.
2007. View Article : Google Scholar
|
|
6
|
Thiery JP, Acloque H, Huang RY, et al:
Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elias MC, Tozer KR, Silber JR, et al:
TWIST is expressed in human gliomas and promotes invasion.
Neoplasia. 7:824–837. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo GQ, Li JH, Wen JF, et al: Effect and
mechanism of the Twist gene on invasion and metastasis of gastric
carcinoma cells. World J Gastroenterol. 14:2487–2493. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia J, Zhang W, Liu JY, Chen G, et al:
Epithelial mesenchymal transition is required for acquisition of
anoikis resistance and metastatic potential in adenoid cystic
carcinoma. PLoS One. 7:e515492012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murtaza I, Adhami VM, Hafeez BB, et al:
Fisetin, a natural flavonoid, targets chemoresistant human
pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of
NF-kappaB. Int J Cancer. 125:2465–2473. 2009. View Article : Google Scholar
|
|
13
|
Li J, Cheng Y, Qu W, et al: Fisetin, a
dietary flavonoid, induces cell cycle arrest and apoptosis through
activation of p53 and inhibition of NF-kappa B pathways in bladder
cancer cells. Basic Clin Pharmacol Toxicol. 108:84–93. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ying TH, Yang SF, Tsai SJ, et al: Fisetin
induces apoptosis in human cervical cancer HeLa cells through
ERK1/2-mediated activation of caspase-8-/caspase-3-dependent
pathway. Arch Toxicol. 86:263–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khan N, Asim M, Afaq F, et al: A novel
dietary flavonoid fisetin inhibits androgen receptor signaling and
tumor growth in athymic nude mice. Cancer Res. 68:8555–8563. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng H, Li LL, Hu DS, et al: Role of
Epstein-Barr virus encoded latent membrane protein 1 in the
carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol.
4:185–196. 2007.PubMed/NCBI
|
|
17
|
Chen Y and Chen XY: Effect of Epstein-Barr
virus latent membrane protein 1 (LMP1) on apoptosis of
nasopharyngeal carcinoma cell line CNE1. Ai Zheng. 21:498–503.
2002.(In Chinese).
|
|
18
|
Guo L, Tang M, Yang L, et al: Epstein-Barr
virus oncoprotein LMP1 mediates survivin upregulation by p53
contributing to G1/S cell cycle progression in nasopharyngeal
carcinoma. Int J Mol Med. 29:574–580. 2012.PubMed/NCBI
|
|
19
|
Lo KW, To KF and Huang DP: Focus on
nasopharyngeal carcinoma. Cancer Cell. 5:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brabletz T: EMT and MET in metastasis:
where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ploenes T, Scholtes B, Krohn A, et al:
CC-chemokine ligand 18 induces epithelial to mesenchymal transition
in lung cancer A549 cells and elevates the invasive potential. PLoS
One. 8:e530682013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sánchez-García I: The crossroads of
oncogenesis and metastasis. N Engl J Med. 360:297–299.
2009.PubMed/NCBI
|
|
24
|
Wang WS, Yang XS, Xia M, et al: Silencing
of twist expression by RNA interference suppresses
epithelial-mesenchymal transition, invasion, and metastasis of
ovarian cancer. Asian Pac J Cancer Prev. 13:4435–4439. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Yang M, Gan L, et al: DLX4
upregulates TWIST and enhances tumor migration, invasion and
metastasis. Int J Biol Sci. 8:1178–1187. 2012. View Article : Google Scholar : PubMed/NCBI
|
